Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02525692
Title Oral ONC201 in Recurrent GBM, H3 K27M Glioma, and Midline Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Oncoceutics, Inc.
Age Groups: child | adult | senior
Covered Countries USA

Additional content available in CKB BOOST